The DiaMove Study: Effects of neurologists* communication about a diagnosis of Parkinsons disease on patients well-being. A prospective mixed-methods study.

The DiaMove Study: Effects of neurologists* communication about a diagnosis of Parkinson*s disease on patients* well-being. A prospective mixed-methods study. - DiaMove

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54577

Enrollment

Registered

2020-03-03

Start date

2020-06-30

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants are: 1. patients referred to a Neurology out-patient clinic by the GP for a first diagnostic consultation for suspected Parkinson disease; 2. the significant others of the patients in 1. Inclusion criteria: For patients: • 18 years of age or older • Referral to Neurology outpatient clinic for suspected Parkinson*s disease • Participation in the study (evidenced by the Informed Consent) by the neurologist to whom the patient has initially been referred For patients* significant others: • 18 years of age or older • Accompanying patient to the Neurology outpatient appointment(s).

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: For patients: - Insufficient Dutch language proficiency - Pre-existing, known severe cognitive condition that would hinder questionnaire completion and/or interview participation - Previous analysis for suspected PD by a neurologist - Other severe medical condition which may lead to reduced life expectancy or severe impairments to daily life - No informed consent For patients* significant others: - Insufficient Dutch language proficiency - Severe cognitive impairment that would hinder questionnaire completion and/or interview participation - No informed consent

Design outcomes

Primary

Measure	Time frame
Aim 1: Duration and content of information provided during diagnostic and post-diagnostic consultations by the neurologist; Number and type of uncertainty statements by the neurologist; Aim 2: Experienced levels of stress by the neurologist; Aim 3: Patients* and their significant others* levels of satisfaction and trust, feelings of uncertainty and anxiety, recall of information, and in-depth reports about the communication with the neurologist.	—

Measure

Time frame

Aim 1: Duration and content of information provided during diagnostic and post-diagnostic consultations by the neurologist; Number and type of uncertainty statements by the neurologist; Aim 2: Experienced levels of stress by the neurologist; Aim 3: Patients* and their significant others* levels of satisfaction and trust, feelings of uncertainty and anxiety, recall of information, and in-depth reports about the communication with the neurologist.

—

Countries

Netherlands

Outcome results